Marion Subklewe

59PUBLICATIONS
404CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Aug 11, 2026
Predictive Models for Toxicities after CAR T-cell Therapy: Challenges and Opportunities.

|Jul 16, 2026
Durable efficacy and manageable long-term safety of lisocabtagene maraleucel in 3L+ FL: 3-year update from TRANSCEND FL.

|Apr 14, 2026
Inhibition of high CXCR4 with motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

Enise Ceran, Sonia Jaramillo, Anne Kathrin Merbach

|Jan 16, 2026
Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland.

Linda Simon, Vladan Vucinic, Kai Rejeski

|Jan 05, 2026
Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.

Danny Luan, Ori Ben Valid, Ofrat Beyar-Katz

|Dec 15, 2025
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

Pageof 10

Frequent Collaborators

21 joint publications

Veit L Bücklein

11 joint publications

Viktoria Blumenberg

11 joint publications

Michael D Jain

11 joint publications

Gloria Iacoboni